Skip to main content

Palladyne AI Reports Fourth Quarter and Full Year 2025 Results and Reiterates 2026 Revenue Guidance of $24 to $27 Million

2026 revenue guidance implies 357% to 415% year-over-year growth, with backlog increasing more than 30% since year-end to nearly $18 million midway through the first quarter

2025 culminated in structural repositioning following November acquisitions

Launch of Palladyne Defense and commercialization of Palladyne IQ 2.0 position Company for execution in 2026

Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs, and advanced aerospace engineering services, today announced financial results for the fourth quarter and full year ended December 31, 2025.

Ben Wolff, President and Chief Executive Officer of Palladyne AI, commented:

“2025 was a year of operational validation that culminated in structural transformation. In November, we completed the acquisitions of GuideTech, Warnke Precision Machining and MKR Fabricators and launched Palladyne Defense. That repositioning expanded our capabilities beyond autonomy software to include advanced avionics, engineering services, proprietary airframe and missile development and certified U.S.-based manufacturing. We exited 2025 as a fundamentally different company, with expanded backlog, deeper defense engagement and an integrated autonomy-to-manufacturing stack aligned with evolving Department of War priorities.

“Over the past few months, we have moved decisively to execute across the defense and commercial parts of our business. We commercially released Palladyne IQ 2.0, integrating feedback from potential customers into its development, and recently signed our first customer for the product. We also introduced IntelliSwarm, integrating SwarmOS into the BRAIN X2 flight module, and demonstrated collaborative autonomy between our recently branded Gremlin-X™ (formerly Project Banshee) platform running IntelliSwarm and multiple Red Cat platforms operating with SwarmOS, validating distributed, multi-platform collaboration in real-world environments.

“We also established our presence in the space domain. Through our satellite-related development work with the Air Force Research Laboratory, we are extending SwarmOS capabilities to integrate communications with space-based systems. Separately, our engagement with Portal Space Systems advances propulsion design for next-generation space platforms and establishes a foundation for potential future collaboration surrounding collaborative autonomy.”

Recent Strategic and Operational Highlights

  • Launched Palladyne Defense following the acquisitions of GuideTech, Warnke Precision Machining and MKR Fabricators, integrating autonomy software, advanced avionics engineering and design, components, proprietary UAVs and missile systems, and certified U.S.-based manufacturing;
  • Commercially released Palladyne IQ 2.0 and signed an initial customer following customer-driven refinement throughout 2025;
  • Hired Matt Muta as President of Commercial and Industrial to focus on capturing commercial opportunities;
  • Branded Project Banshee (next-generation autonomous UAV mini-bomber platform currently under development) as Gremlin-X;
  • Demonstrated collaborative autonomous swarming between the Gremlin-X platform utilizing IntelliSwarm, and multiple Red Cat platforms operating with SwarmOS;
  • Expanded into the space domain through satellite-related development work with the Air Force Research Laboratory and propulsion design engagement with Portal Space Systems;
  • Progressed development milestones across Gremlin-X and new BRAIN variants;
  • Secured missile propulsion subsystem contract from a new defense prime customer; and
  • Strengthened intellectual property portfolio through a new patent issuance supporting advanced swarming and decentralized autonomy architectures and filed four new patent applications related to Palladyne’s AI software products and technologies.

Fourth Quarter 2025 Financial Highlights (vs. fourth quarter 2024)

  • Revenue increased 118% to $1.7 million compared to $0.8 million;
  • Operating loss of ($9.3) million compared to ($6.5) million;
  • GAAP net loss and basic and diluted loss per share (EPS) of ($1.5) million, and ($0.04), compared to ($53.0) million, and ($1.75);
  • *Non-GAAP net loss and Non-GAAP EPS of ($6.9) million, and ($0.16), compared to ($5.2) million, and ($0.17);
  • Cash, cash equivalents and marketable securities totaled $47.0 million at December 31, 2025;
  • Backlog as of December 31, 2025, was $13.5 million.

Full Year 2025 Financial Highlights (vs. full year 2024)

  • Revenue decreased 33% to $5.2 million compared to $7.8 million;
  • Operating loss of ($32.4) million compared to ($26.9) million;
  • GAAP net income and diluted EPS of $10.0 million, and $0.24, compared to a net loss of ($72.6) million, and ($2.71);
  • *Non-GAAP net loss and Non-GAAP EPS of ($25.2) million, and ($0.60), compared to ($22.6) million, and ($0.84).

*see GAAP to Non-GAAP reconciliation at the end of this press release

2026 Outlook

The Company reiterates its previously announced full year 2026 revenue guidance of $24 million to $27 million, representing expected year-over-year growth of approximately 357% to 415% compared to 2025 revenue of $5.2 million. Supporting this guidance, Palladyne AI had a contracted 12-18 month backlog of nearly $18.0 million as of mid-February 2026, a more than 30% increase since December 31, 2025.

The guidance reflects revenue contributions from acquired entities, backlog conversion and monetization of development programs secured during and following the Company’s fourth quarter repositioning. Management believes recent contract wins and expanding program activity across air and space domains provide increased visibility into achieving these targets.

The Company continues to advance product maturation milestones and pursue early customer wins across Palladyne IQ 2.0, SwarmOS and BRAIN platforms while maintaining a disciplined focus on execution.

Conference Call

Palladyne AI will host a conference call today, Thursday, March 5, 2026, at 8:00 a.m. Eastern Time to discuss its financial and operational results, strategy and future opportunities.

Dial-in and Webcast Information

 

Date/Time:

Thursday, March 5, 2026, at 8:00 a.m. Eastern Time

Toll-Free (North America):

1-877-407-0789

Toll/International:

1-201-689-8562

Conference Call ID:

13758938

Webcast Link:

 

https://viavid.webcasts.com/starthere.jsp?ei=1753897&tp_key=50d08a7821
Call me™: Participants can use the Guest dial-in #s above and be answered by an operator, or click the Call me™ link for instant telephone access to the event. Call me™ link will be made active 15 minutes prior to the scheduled start time. https://callme.viavid.com/viavid/?callme=true&passcode=13757186&h=true&info=company&r=true&B=6
Replay Information
 

Toll-Free (North America)

1-844-512-2921

Toll/International:

1-412-317-6671

Conference Call ID:

13758938

Expiration:

Thursday, March 19, 2026, 11:59 p.m. Central Time

About Palladyne AI

Palladyne AI is a U.S.-based technology company developing patented embodied artificial intelligence, collaborative autonomy solutions, advanced avionics, autonomous systems, advanced UAV engineering services, and precision-manufactured components for defense and industrial markets. Palladyne AI delivers secure, American-developed and operated platforms designed to meet the stringent requirements of U.S. government and public-sector customers, including data sovereignty, security, and compliance.

Palladyne AI’s embodied AI is designed to operate in complex, contested, and high-risk environments, enabling distributed tasking, human-on-the-loop decision-making, degraded-communications resilience, and multi-domain coordination. Its platform-agnostic autonomy stack combines real-time sensor fusion, adaptive AI models, and edge-native orchestration - without vendor lock-in - to support autonomous and collaborative systems across air, ground, maritime, and industrial domains where performance, resilience, and trust are paramount. For more information about Palladyne AI, including GuideTech and Palladyne Defense, please visit www.palladyneai.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the capabilities or future capabilities of Palladyne AI’s technology and related products, including IntelliSwarm; anticipated growth, operating scale and operating inflection of the Company; the applicability of Palladyne AI’s products and technology to the space domain; 2026 expected financial performance, including expected revenue and sources of revenue; the time of customer acquisition, revenue recognition and backlog realization; the benefits of its AI software and other products and the markets for its products and services; and the applicability of IntelliSwarm and its autonomy software to different kinds of machines (such as UAVs, UGVs and ROVs); future development and qualification plans; and intended future target customers. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or “continue” or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results, or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Palladyne AI’s management’s current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Palladyne AI is not under any obligation and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Readers should carefully review the statements set forth in the reports which Palladyne AI has filed or will file from time to time with the Securities and Exchange Commission (the “SEC”), in particular the risks and uncertainties set forth in the sections of those reports entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” for a description of risks facing Palladyne AI and that could cause actual events, results or performance to differ from those indicated in the forward-looking statements contained herein. The documents filed by Palladyne AI with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

PALLADYNE AI CORP.

CONSOLIDATED BALANCE SHEETS

(unaudited)

(in thousands, except share data)

 

 

 

As of

 

 

 

December 31, 2025

 

 

December 31, 2024

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

18,219

 

 

$

31,188

 

Marketable securities

 

 

28,836

 

 

 

8,883

 

Accounts receivable, net of allowance for credit losses of $0.0 million and $0.3 million at December 31, 2025 and 2024, respectively

 

 

1,055

 

 

 

134

 

Unbilled receivables

 

 

2,455

 

 

 

1,179

 

Inventories

 

 

339

 

 

 

71

 

Prepaid expenses and other current assets

 

 

1,653

 

 

 

1,275

 

Total current assets

 

 

52,557

 

 

 

42,730

 

Property and equipment, net

 

 

8,889

 

 

 

4,244

 

Intangible assets, net

 

 

10,430

 

 

 

 

Goodwill

 

 

14,731

 

 

 

 

Operating lease assets

 

 

8,645

 

 

 

8,841

 

Other non-current assets

 

 

460

 

 

 

438

 

Total assets

 

$

95,712

 

 

$

56,253

 

Liabilities and stockholders’ equity (deficit)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

1,058

 

 

$

435

 

Accrued liabilities

 

 

3,550

 

 

 

2,919

 

Current operating lease liabilities

 

 

1,058

 

 

 

1,079

 

Total current liabilities

 

 

5,666

 

 

 

4,433

 

Warrant liabilities

 

 

2,772

 

 

 

51,396

 

Operating lease liabilities

 

 

9,725

 

 

 

9,957

 

Other non-current liabilities

 

 

2,874

 

 

 

 

Total liabilities

 

 

21,037

 

 

 

65,786

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

Common stock, $0.0001 par value, 165,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 46,117,164 and 33,883,894 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively

 

 

5

 

 

 

3

 

Additional paid-in capital

 

 

555,451

 

 

 

481,289

 

Accumulated other comprehensive income

 

 

11

 

 

 

6

 

Accumulated deficit

 

 

(480,792

)

 

 

(490,831

)

Total stockholders’ equity (deficit)

 

 

74,675

 

 

 

(9,533

)

Total liabilities and stockholders’ equity (deficit)

 

$

95,712

 

 

$

56,253

 

PALLADYNE AI CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(in thousands, except share and per share data)

 

Three Months Ended December 31,

 

Year Ended December 31,

 

2025

 

 

2024

 

2025

 

 

2024

 

Revenue, net

$

1,661

 

 

$

761

 

$

5,246

 

 

$

7,786

 

Operating expenses:​

 

 

 

 

 

 

 

 

 

 

Cost of revenue (exclusive of items shown separately below)

 

1,402

 

 

 

554

 

 

2,690

 

 

 

3,488

 

Research and development

 

3,758

 

 

 

2,612

 

 

12,899

 

 

 

10,437

 

General and administrative

 

4,683

 

 

 

3,461

 

 

17,199

 

 

 

16,842

 

Sales and marketing

 

1,014

 

 

 

618

 

 

4,744

 

 

 

4,134

 

Asset write-down and restructuring

 

 

 

 

 

 

 

 

 

 

 

(192

)

Total operating expenses

 

10,975

 

 

 

7,245

 

 

37,650

 

 

 

34,709

 

Loss from operations

 

(9,314

)

 

 

(6,484

)

 

(32,404

)

 

 

(26,923

)

Interest income, net

 

432

 

 

 

277

 

 

1,944

 

 

 

1,244

 

Gain (loss) on warrant liabilities

 

 

4,630

 

 

 

(46,760

)

 

 

37,740

 

 

 

(46,935

)

Other income, net

 

221

 

 

 

 

 

221

 

 

 

2

 

Income (loss) before income tax expense

 

(4,031

)

 

 

(52,967

)

 

7,501

 

 

 

(72,612

)

Income tax benefit (expense)

 

2,538

 

 

 

(2

)

 

2,538

 

 

 

(5

)

Net income (loss)

$

(1,493

)

 

$

(52,969

)

$

10,039

 

 

$

(72,617

)

Net income (loss) per share

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.04

)

 

$

(1.75

)

$

0.26

 

 

$

(2.71

)

Diluted

 

$

(0.04

)

 

$

(1.75

)

 

$

0.24

 

 

$

(2.71

)

Weighted-average shares used in computing net income (loss) per share

 

 

 

 

 

 

 

 

 

 

Basic

 

42,329,510

 

 

 

30,277,019

 

 

38,841,116

 

 

 

26,774,895

 

Diluted

 

 

42,329,510

 

 

 

30,277,019

 

 

42,125,932

 

 

 

26,774,895

 

PALLADYNE AI CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(in thousands)

 

 

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income (loss)

 

$

10,039

 

 

$

(72,617

)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

Stock-based compensation

 

 

4,447

 

 

 

2,805

 

Depreciation of property and equipment

 

 

974

 

 

 

825

 

Amortization of intangible assets

 

 

118

 

 

 

 

Change in fair value of warrant liabilities

 

 

(37,740

)

 

 

46,935

 

Allowance for credit losses

 

 

 

 

 

285

 

Amortization of investment discount

 

 

(1,386

)

 

 

(75

)

Deferred income tax benefit

 

 

(2,541

)

 

 

 

Changes in operating assets and liabilities, net of acquisitions:

 

 

 

 

 

 

Accounts receivable

 

 

1,096

 

 

 

136

 

Unbilled receivable

 

 

(960

)

 

 

855

 

Inventories

 

 

58

 

 

 

994

 

Prepaid expenses and other current assets

 

 

(132

)

 

 

1,048

 

Operating lease assets & other non-current assets

 

 

1,005

 

 

 

1,242

 

Accounts payable

 

 

(708

)

 

 

(819

)

Accrued liabilities and current operating lease liabilities

 

 

(904

)

 

 

(3,164

)

Operating lease liabilities

 

 

(1,003

)

 

 

(1,077

)

Net cash used in operating activities

 

 

(27,637

)

 

 

(22,627

)

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(713

)

 

 

(265

)

Acquisition of a business, net of cash acquired

 

 

(5,302

)

 

 

 

Purchases of marketable securities

 

 

(75,563

)

 

 

(8,859

)

Maturities of marketable securities

 

 

57,000

 

 

 

16,000

 

Net cash (used in) provided by investing activities

 

 

(24,578

)

 

 

6,876

 

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

74

 

 

 

130

 

Proceeds from issuance of common stock under ESPP

 

 

148

 

 

 

 

Proceeds from the exercise of warrants

 

 

6,419

 

 

 

 

Shares repurchased for payment of tax withholdings

 

 

 

 

 

(105

)

Payment of obligations under finance leases

 

 

(20

)

 

 

(3

)

Payment of debt obligations

 

 

(3,696

)

 

 

 

Proceeds from the issuance of warrants

 

 

 

 

 

4,432

 

Proceeds from issuance of common stock

 

 

36,371

 

 

 

20,028

 

Payment of transaction costs related to issuance of common stock

 

 

(50

)

 

 

(682

)

Net cash provided by financing activities

 

 

39,246

 

 

 

23,800

 

Net (decrease) increase in cash and cash equivalents

 

 

(12,969

)

 

 

8,049

 

Cash and cash equivalents at beginning of period

 

 

31,188

 

 

 

23,139

 

Cash and cash equivalents at end of period

 

$

18,219

 

 

$

31,188

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

Cash paid for income taxes

 

$

2

 

 

$

10

 

Supplemental disclosure of non-cash activities:

 

 

 

 

 

 

Common stock issued in connection with a business acquisition

 

$

15,872

 

 

$

 

Purchases of property and equipment financed through notes payable

 

$

113

 

 

$

 

Warrant liabilities reclassified to equity upon exercise

 

$

10,883

 

 

$

 

PALLADYNE AI CORP.
NON-GAAP FINANCIAL MEASURES
(Unaudited)

 

To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our financial results, we have presented in this release non-GAAP net income (loss) and non-GAAP net income (loss) per share (non-GAAP EPS), each of which are non-GAAP financial measures. Non-GAAP net income (loss) and non-GAAP EPS are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies.

We define non-GAAP net income (loss) as our GAAP measures of net income (loss) excluding the impacts of stock-based compensation expense, gain or loss on change in fair value of warrant liabilities, expenses related to business combinations and other non-recurring or non-operating expenses. We define non-GAAP EPS as non-GAAP net income (loss) divided by weighted average outstanding shares.

The most directly comparable GAAP measures to non-GAAP net income (loss) and non-GAAP EPS are net income (loss) and EPS, respectively. We believe excluding the impact of the previously listed items in calculating non-GAAP net income (loss) and non-GAAP EPS can provide a useful measure for period-to-period comparisons of our core operating performance. We monitor, and have presented in this release, non-GAAP net income (loss) and non-GAAP (EPS) because they are each a key measure used by our management and board of directors to understand and evaluate our operating performance and to establish budgets. We believe non-GAAP net income (loss) and non-GAAP EPS help identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we include in net income (loss) but not in non-GAAP net income (loss). Accordingly, we believe non-GAAP net income (loss) and non-GAAP (EPS) provide useful information to investors, analysts and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance.

Non-GAAP net income (loss) and non-GAAP (EPS) are not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of non-GAAP net income (loss) and non-GAAP EPS rather than net income (loss) and EPS, which is for each the most directly comparable financial measure calculated and presented in accordance with GAAP. In addition, the expenses and other items that we exclude in our calculations of non-GAAP net income (loss) and non-GAAP EPS may differ from the expenses and other items, if any, that other companies may exclude from non-GAAP net income (loss) and non-GAAP EPS when they report their operating results, limiting the usefulness of non-GAAP net income (loss) and non-GAAP EPS for comparative purposes.

In addition, other companies may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP net income (loss) and non-GAAP EPS as tools for comparison.

The following table reconciles non-GAAP net income (loss) to net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP (in thousands, except share and per share data):

Three Months Ended December 31,

 

Year Ended December 31,

 

2025

 

 

2024

 

2025

 

 

2024

 

Net income (loss)

 

$

(1,493

)

 

$

(52,969

)

 

$

10,039

 

 

$

(72,617

)

Non-GAAP adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

 

1,101

 

 

 

578

 

 

 

4,447

 

 

 

2,805

 

(Gain) loss on warrant liability

 

 

(4,630

)

 

 

46,760

 

 

 

(37,740

)

 

 

46,935

 

Asset write-down and restructuring (1)

 

 

 

 

 

 

 

 

 

 

 

(192

)

Transaction Expenses (2)

 

 

631

 

 

 

466

 

 

 

631

 

 

 

466

 

Income tax benefit related to business combinations

 

 

(2,541

)

 

 

 

 

 

(2,541

)

 

 

 

Non-GAAP net loss

 

$

(6,932

)

 

$

(5,165

)

 

$

(25,164

)

 

$

(22,603

)

Net income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.04

)

 

$

(1.75

)

 

$

0.26

 

 

$

(2.71

)

Diluted

 

$

(0.04

)

 

$

(1.75

)

 

$

0.24

 

 

$

(2.71

)

Non-GAAP net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.16

)

 

$

(0.17

)

 

$

(0.65

)

 

$

(0.84

)

Diluted

 

$

(0.16

)

 

$

(0.17

)

 

$

(0.60

)

 

$

(0.84

)

Weighted-average shares used in computing net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

42,329,510

 

 

 

30,277,019

 

 

 

38,841,116

 

 

 

26,774,895

 

Diluted

 

 

42,329,510

 

 

 

30,277,019

 

 

 

42,125,932

 

 

 

26,774,895

 

(1)

Asset write-down and restructuring benefit for the twelve months ended December 31, 2024, reflects restructuring charges, net of estimate adjustments, and is included within general and administrative expenses within the consolidated statements of operations.

(2)

Transaction expenses for the twelve months ended December 31, 2025, primarily consisted of legal and accounting costs incurred in connection with the business combinations completed in November 2025. Transaction expenses for the twelve months ended December 31, 2024, primarily consisting of brokerage, legal and accounting fees incurred in connection with our issuance of warrants in November 2024. In both periods, these costs are included within general and administrative expenses within the consolidated statements of operations.

 

"2025 was a year of operational validation that culminated in structural transformation," said Ben Wolff, President and Chief Executive Officer of Palladyne AI.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.82
+0.00 (0.00%)
AAPL  262.52
+0.00 (0.00%)
AMD  202.07
+0.00 (0.00%)
BAC  50.30
+0.00 (0.00%)
GOOG  303.45
+0.00 (0.00%)
META  667.73
+0.00 (0.00%)
MSFT  405.20
+0.00 (0.00%)
NVDA  183.04
+0.00 (0.00%)
ORCL  152.37
+0.00 (0.00%)
TSLA  405.94
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.